CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1‑Sj26GST

  • Authors:
    • Jun Lu
    • Shan Jiang
    • Song Ye
    • Yun Deng
    • Shuai Ma
    • Chao‑Pin Li
  • View Affiliations

  • Published online on: April 30, 2013     https://doi.org/10.3892/br.2013.99
  • Pages: 609-613
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Schistosomiasis is considered one of the most important neglected tropical diseases and remains a major public health problem in endemic countries. Toll‑like receptor (TLR) ligands have been investigated as potential vaccine adjuvants for tumor and virus immunotherapy. However, few TLR ligands affecting schistosoma vaccines have been characterized. In this study, we evaluated a TLR9 ligand (CpG oligodeoxynucleotide 1826, CpG) as an adjuvant for a partially protective DNA vaccine encoding a 26‑kDa glutathione S‑transferase of Schistosoma japonicum (pVAX1‑Sj26GST). Vaccination with pVAX1‑Sj26GST in combination with CpG inhibited Treg immunosuppressive function, upregulated the production of interferon (IFN)‑γ, tumor necrosis factor (TNF)‑α, interleukin (IL)‑4, IL‑10, IL‑2 and IL‑6, and decreased CD4+CD8+Foxp3+ expression in vitro, which may contribute to the escape from Treg‑mediated suppression during vaccination, allowing expansion of antigen‑specific T cells against pathogens. In conclusion, our data demonstrated that selective TLR ligand combination may increase protective efficacy against schistosomiasis, which may synergistically antagonize Treg‑mediated suppression.
View Figures
View References

Related Articles

Journal Cover

July-August 2013
Volume 1 Issue 4

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lu J, Jiang S, Ye S, Deng Y, Ma S and Li CP: CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1‑Sj26GST. Biomed Rep 1: 609-613, 2013.
APA
Lu, J., Jiang, S., Ye, S., Deng, Y., Ma, S., & Li, C. (2013). CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1‑Sj26GST. Biomedical Reports, 1, 609-613. https://doi.org/10.3892/br.2013.99
MLA
Lu, J., Jiang, S., Ye, S., Deng, Y., Ma, S., Li, C."CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1‑Sj26GST". Biomedical Reports 1.4 (2013): 609-613.
Chicago
Lu, J., Jiang, S., Ye, S., Deng, Y., Ma, S., Li, C."CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1‑Sj26GST". Biomedical Reports 1, no. 4 (2013): 609-613. https://doi.org/10.3892/br.2013.99